Fund Mojo Newsletter

Fund Mojo on Facebook Follow FundMojo on Twitter Fund Update

Featured Advisor:
Lisa M Andrews

Madison, WI
(608) 204-5960
More Details

Historical Analysis

Partners

Fund Mojo help you discover the best fund managers, funds, and related information

Fund Intelligence | Best Managers | FBIOX Insights | FBIOX Score | FBIOX Performance | FBIOX News | FBIOX Allocation | FBIOX Holdings Change

Fidelity Select Biotechnology Portfolio (FBIOX) Fund Ranking and Research

Ranking, Research and Recommendation of Fidelity Select Biotechnology Portfolio (FBIOX) Fund

    Last Trade: $250.97 on 2/26/2015, Change: +0.89 (0.36%)

 

Graph of Fidelity Select Biotechnology Portfolio Fund (FBIOX) ManagerFund Manager - Rajiv Kaul

Fund Manager Information

Fund Manager Tenure: 9.4 years
Fund Family: Fidelity Investments
Fund Category: Health
Fund Performance: Jan 30, 2015
Fundmojo Fund Grade: *Master* (Score: 0.87)     (What does this score mean?)
Kaul is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in 1996, he has worked as a research analyst and portfolio manager. Kaul also manages another Fidelity fund. He is the recipient of the Kann Rasmusson Environment Award, the Dean's Summer Research Award and a Ford Undergraduate Fellowship.  Get more insights on Rajiv Kaul

 

Graph of Fidelity Select Biotechnology Portfolio Fund (FBIOX) ProfileFidelity Select Biotechnology Portfolio Fund (FBIOX) Profile

Fund Profile and Description

Fidelity Select Biotechnology Portfolio Fund seeks capital appreciation. Fidelity Select Biotechnology Portfolio Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. These companies may include, companies involved in the research, development, or production of pharmaceuticals, including veterinary drugs. It may invest in securities of foreign issuers. Fidelity Select Biotechnology Portfolio Fund is non-diversified.

 

Fidelity Select Biotechnology Portfolio (FBIOX) Fund Strength What we like about Fidelity Select Biotechnology Portfolio (FBIOX) Fund

Data for Fidelity Select Biotechnology Portfolio Fund (FBIOX) as of Jan 30, 2015

  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) management has been with Fidelity Select Biotechnology Portfolio Fund for 9.4 years
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) has good short-term performance (1-year return 27.26% vs 25.42% Health category median performance)
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) has good mid-term performance (3-year return 42.49% vs 28.32% Health category median performance)
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) has good Long-term performance (5-year return 33.26% vs 20.69% Health category median performance)
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) ratio of up-years vs down years is greater than 2
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) has a Morningstar rating of 4 and above
  • Asset base in Fidelity Select Biotechnology Portfolio Fund (FBIOX) has been consistently increasing at a reasonable pace in the last 2 months. It shows investor confidence and market support
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) has an annual stock turnover rate of 35.00% vs Health average of 56.11%. It is good that Fidelity Select Biotechnology Portfolio management does not trade extensively for its return.
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) has a lower expense ratio than its Health average: 0.75% vs 1.43%
  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) is a true no-load fund as it has no load and no 12b1 promotion, distributions, marketing expenses

Fidelity Select Biotechnology Portfolio Fund (FBIOX) Weakness What we are cautious about Fidelity Select Biotechnology Portfolio (FBIOX) Fund

Data for Fidelity Select Biotechnology Portfolio Fund (FBIOX) as of Jan 30, 2015

  • Fidelity Select Biotechnology Portfolio Fund (FBIOX) is more volatile than its peers as it has a 3-year Standard Deviation of 20.72 that is higher than category average of 12.66
  • As a Health focused fund, Fidelity Select Biotechnology Portfolio Fund (FBIOX) is less diversified and has inherited sector risks associated with the fund
See Fidelity Select Biotechnology Portfolio Fund (FBIOX) performance details as of Jan 30, 2015

 

What do you think?

 

Compare Fidelity Select Biotechnology Portfolio Fund (FBIOX)Compare with other top Health category mutual funds

Aadditional top Health mutual funds for your consideration

FundYear to Date1 Year3 year5 year
Fidelity Select Biotechnology Portfolio6.5927.2642.4933.26
Franklin Biotechnology Discovery A (FBDIX)5.5127.0139.9330.79Compare
Hartford Healthcare HLS IA (HIAHX)3.0326.1030.9022.33Compare
Janus Global Life Sciences T (JAGLX)4.3631.3736.6725.89Compare

See top fund managers for Health Category Funds

 

Compare Fidelity Select Biotechnology Portfolio Fund (FBIOX)Compare with Health category ETFs

Some Health ETFs for your consideration

ETFYear to DateOne YearThree Year
First Trust NYSE Arca Biotech Index (FBT)7.72%46.10%40.59%
SPDR S&P Biotech (XBI)7.07%34.56%38.37%
PowerShares Dynamic Pharmaceuticals (PJP)5.44%32.11%36.64%
RBS Global Big Pharma ETN (DRGS)4.33%30.60%28.14%
iShares Dow Jones US Pharmaceuticals (IHE)2.13%29.66%27.55%

 

Graph of Fidelity Select Biotechnology Portfolio Fund (FBIOX) Net Asset TrackingFidelity Select Biotechnology Portfolio (FBIOX) Fund Net Asset

Track net asset change of Fidelity Select Biotechnology Portfolio fund (FBIOX)

DateNet Asset
01/2015$12.20B
12/2014$10.92B
11/2014$10.45B
More historic net asset information on Fidelity Select Biotechnology Portfolio Fund (FBIOX)

  

Graph of Fidelity Select Biotechnology Portfolio Fund (FBIOX) Portfolio TrackingFidelity Select Biotechnology Portfolio (FBIOX) Fund Portfolio Allocation

Track portfolio allocation change of Fidelity Select Biotechnology Portfolio fund (FBIOX)

DateCashStockBondOther
12/20140.39%98.96%0%0%
11/20140.31%98.98%0%0%
10/20140.25%99.18%0%0%
Click here to see more historic asset allocation information on Fidelity Select Biotechnology Portfolio Fund (FBIOX)

 

graph of Fidelity Select Biotechnology Portfolio Fund (FBIOX) Top 10 Position TrackingTop 10 Holdings in Fidelity Select Biotechnology Portfolio (FBIOX) Fund

Discover what Fidelity Select Biotechnology Portfolio Fund (FBIOX) manager is buying

Dec 30, 2014
Gilead Sciences, Inc. [6.57%]
Celgene Corporation [5.69%]
Vertex Pharmaceuticals Incorpor [5.24%]
Biogen Idec Inc. [5.13%]
Alexion Pharmaceuticals, Inc. [4.44%]
Regeneron Pharmaceuticals, Inc. [4.22%]
Receptos, Inc. [2.56%]
BioMarin Pharmaceutical Inc. [2.45%]
Medivation, Inc. [2.32%]
Puma Biotechnology Inc Common S [1.99%]

Nov 29, 2014
Gilead Sciences, Inc. [9.54%]
Vertex Pharmaceuticals Incorpor [5.44%]
Celgene Corporation [5.38%]
Alexion Pharmaceuticals, Inc. [4.54%]
Regeneron Pharmaceuticals, Inc. [4.43%]
Receptos, Inc. [2.89%]
Medivation, Inc. [2.82%]
Puma Biotechnology Inc Common S [2.49%]
BioMarin Pharmaceutical Inc. [2.32%]
Incyte Corporation [1.9%]

Oct 30, 2014
Gilead Sciences, Inc. [11.13%]
Vertex Pharmaceuticals Incorpor [5.58%]
Celgene Corporation [5.3%]
Alexion Pharmaceuticals, Inc. [4.38%]
Regeneron Pharmaceuticals, Inc. [4.2%]
Intercept Pharmaceuticals, Inc. [3%]
Puma Biotechnology Inc Common S [2.93%]
Medivation, Inc. [2.69%]
BioMarin Pharmaceutical Inc. [2.17%]
Jazz Pharmaceuticals plc [1.75%]
Click here for Stock Holding Change Map in Fidelity Select Biotechnology Portfolio Fund (FBIOX)

  

Latest News on Fidelity Select Biotechnology Portfolio (FBIOX) Fund

See what is happening with Fidelity Select Biotechnology Portfolio Fund (FBIOX)

 

Fidelity Select Biotechnology Portfolio Fund (FBIOX) Related ResourcesSee more information on Fidelity Select Biotechnology Portfolio (FBIOX) Fund

Popular pages on Fidelity Select Biotechnology Portfolio (FBIOX) Fund